Software offers the user the ability to completely deconvolute a biofluid spectrum into the individual components and their quantities
Advanced Chemistry Development (ACD/Labs) and Chenomx announce that with the release of version 3.1, Chenomx's Eclipse metabolic profiling software will support NMR spectra prepared using ACD/Labs's 1D NMR Processor.
This development is in response to requests from an evolving and increasingly savvy metabolic profiling industry that requires new ways to ensure careful preparation of the spectra used in metabolic studies. Chenomx Eclipse software offers the user the ability to completely deconvolute a biofluid spectrum into the individual components and their quantities.
These quantities are only available if the spectrum has been carefully prepared. Unfortunately preparation of the NMR spectra of biofluids can be particularly challenging.
The presence of high concentrations of salt water as a solvent, and often low sample sizes combine to create special challenges for the production of the spectrum as well as the subsequent processing and analysis of it.
ACD/Labs has been in the business of processing NMR spectra for many years, and is considered the industry standard in baseline and phase correction.
Chenomx users now have the option of preparing their spectra with ACD/Labs's NMR processing tools, ensuring that their biofluid spectra are prepared using the highest standards.
Brent Lefebvre, NMR product manager for ACD/Labs, commented on the integration: "Users can now employ ACD/Labs's unmatched automatic processing capability before the complete mixture deconvolution that is possible in Chenomx Eclipse.
"This gives our users the best of both worlds by allowing them to utilise both software packages in a single process which exploits the core competency of each for a maximum benefit".
Chris Erasmus, marketing manager for Chenomx, says: "Chenomx recognises the substantial number of users of ACD/Labs software and has developed this information-rich solution as an added value service".
